Summary
Unstable angina, an intermediate stage in acute coronary ischaemic syndromes, accounts for about 50% of all admissions to the coronary care units in the United States today. It may progress to myocardial infarction in 15% of cases in the first 2 days, and the in-hospital mortality rate is 5%. The pathological hallmark of this syndrome, confirmed by angioscopy, is fissure of the atherosclerotic plaque within the coronary artery, leading to platelet adhesion and aggregation and fibrin-platelet thrombus formation, which may accelerate progression of the stenotic lesion.
Management of unstable angina is aimed at ameliorating symptoms and reducing ischaemia, improving ventricular function, preventing recurrent ischaemia, myocardial infarction and death, and lastly, containing progression of the underlying coronary artery disease. Acute management includes bedrest, aspirin, heparin, nitroglycerin (glyceryl trinitrate) infusion and β-blockers and calcium channel blockers in selected cases. After the patient is clinically stabilised, provocative tests and angiography may be performed, to be followed by angioplasty or bypass surgery, if necessary. In cases that are refractory to optimal medical therapy, interventions should be performed on a more emergent basis. Long term management includes aspirin and β-blockers, if there is prior infarction, and control of the conventional risk factors.
Similar content being viewed by others
References
Alison HW, Rüssel JR RO, Mantle JA, Kouchoukos NT, Moraski RE, et al. Coronary anatomy and arteriography in patients with unstable angina pectoris. American Journal of Cardiology 41: 204–209, 1978
Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. Journal of the American College of Cardiology 5: 609–616, 1985
Balsano F, Rizzon P, Violi F, et al. Antiplatelet treatment with ticlopidine in unstable angina. Circulation 82: 17–26, 1990
Berglund U, Wallentin L. Persistent inhibition of platelet function during long-term treatment with 75mg acetyl-salicylic acid daily in men with unstable coronary artery disease. European Heart Journal 12: 428–433, 1991
Black AJ, Brown CS, Feres F, Roubin GS, Douglas JS. Coronary angioplasty and the spectrum of unstable angina pectoris: What determines increased risk? Circulation 78 (Suppl. 2): 11–18, 1988
Brodsky SJ, Halperin JL, Klein MD, Ryan TJ. Intravenous nitro-glycerin infusion in unstable angina. Abstract. Clinical Research 28: 608A, 1980
Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitgroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 64: 1089–1097, 1981
Cairns JA, Fantus IG, Klassen GA. Unstable angina pectoris. American Heart Journal 92: 373–386, 1976
Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, et al. Aspirin, sulfinpyrazone, or both in unstable angina. New England Journal of Medicine 313: 1369–1375, 1985
Chierchia S, Brunelli C, Simonetti I, Lazzari M, Maeri A. Sequence of events in angina at rest: primary reduction in coronary flow. Circulation 61: 759–768, 1980
Cowley MJ, Dorros G, Kelsey F, van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. American Journal of Cardiology 53: 12C-16C, 1984
Cowley MJ, Dorros G, Kelsey F, van Raden M, Detre KM. Emergency coronary bypass surgery after coronary angioplasty: the NHLBI PTCA registry experience. American Journal of Cardiology 53: 22C-26C, 1984
Curfman GD, Heinsimer JA, Lozner EC, Fung H-L. Intravenous nitroglyercin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation 67: 276–282, 1983
Dauwe F, Affake G, Waters DD, Theroux P, Mizgala HF. Intra-venous nitroglycerin in refractory unstable angina. American Journal of Cardiology 43: 416, 1979
de Feyter PJ, Serruys PW. Percutaneous transluminal coronary angioplasty for unstable angina. In Topol EJ (Ed.) Textbook of invasive cardiology, pp. 254–268, WB Saunders Publishing Company, Philadelphia, 1991
deFeyter PJ, Serruys PW, Soward A, van den Brand M, Bos E, et al. Coronary angioplasty for early post-infarction unstable angina. Circulation 54: 460–465, 1986
de Feyter PJ, Serruys PW, van den Brand M, et al. Emergency coronary angioplasty in refractory unstable angina. New England Journal of Medicine 313: 342–347, 1985
de Feyter PJ, Suryapranata H, Serruys PW, Beatt K, van Domburg R, et al. coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavourable early and late outcome. Journal of the American College of Cardiology 12: 324–333, 1988
DePace NL, Herling IM, Kotler MN, Hakki A-H, Spielman SR, et al. Intravenous nitroglycerin for angina. Archives of Internal Medicine 142: 1806–1809, 1982
Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C. Functionally thrombosthenic state in normal platelets following the administration of ticlopidine. Journal of Clinical Investigations 75: 328–338, 1985
Elkayam U, Kulich D, McJutoch N, Roth A, Hsuch W, et al. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 76: 577–584, 1987
Faxon DP, Detre KM, McGabe CH, et al. Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina: report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries. American Journal of Cardiology 53: 131C-135C, 1983
Figueras J, Singh BN, Phil D, Ganz W, Charuzi Y, et al. Mechanism of rest and nocturnal angina. Observations during continuous hemodynamic and electrocardiographic monitoring. Circulation 59: 956–968, 1979
Fitzgerald DJ, Roy L, Robertson RM, Fitzgerald GA. The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. Circulation 70: 297–302, 1984
Flaherty JT. Nitrate tolerance: a review of the evidence. Drugs 37: 523–550, 1989
Forrester JS, Litvack F, Grundfest W, Hickey A. A perspective of coronary disease seen through the arteries of a living man. Circulation 75: 505, 1987
Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, et al. Insights into the pathogenesis of acute ischemic syndromes. Circulation 77: 1212–1220, 1988
Fuster V, Frye RL, Connolly DC, Damelson MA, Eweback LR, et al. Arteriographic patterns early in the onset of coronary syndromes. British Heart Journal 37: 1250–1255, 1975
Gerstenblith G, Ouyang P, Achuff SC, Bulkley BH, Becker LC. Nifedipine in unstable angina: a double-blind, randomized trial. New England Journal of Medicine 306: 885–889, 1982
Gold H, Johns J, Lenbach R, Yasuda T, Grossbard E, et al. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 75, 1192–1199, 1987
Haraphongse M, Tymchak W, Rossal RE. Coronary angioplasty at the time of initial diagnostic coronary angiography on patients with unstable angina. Catheterization and Cardiovascular Diagnosis 14: 73–75, 1988
Harker L, Fuster V. Pharmacology of platelet inhibitors. Journal of the American College of Cardiology 8: 21B-32B, 1986
Held P, Teo KK, Yusuf S. Effects of beta-blockers, calcium-channel blockers, and nitrates in acute myocardial infarction and unstable angina. In Topol EJ (Ed.) Textbook of interventional cardiology, WB Saunders Publishing Company, Philadelphia, 1990
Held P, Yusuf S, Furerg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. British Medical Journal 299: 1187–1192, 1989
Hjemdahl MCE, Lewis HD, Cairns J, Chesebro JH, Fuster C. Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. Journal of the American College of Cardiology 8 (6 Suppl. B): 67B–75B, 1986
Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: a randomized, double-blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. British Heart Journal 56: 400–413, 1986
Holmes DR, Vliestra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty: a report from the PTCA registry of the NHLBI. American Journal of Cardiology 53: 77C-81C, 1984
Kamp O, Beatt KJ, deFeyter PJ, van den Brand M, Suryapranata H, et al. Short-, medium- and long-term follow up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris. American Heart Journal, 117: 991–996, 1989
Kaplan K, Davison R, Parker M, Przbylek J, Teagarden JR, et al. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. American Journal of Cardiology 51: 694–698, 1983
Klimt CR, Knatterud GL, Stamler J, Meier P. Persantine-aspirin reinfarction study, part II: secondary prevention with persantine and aspirin. Journal of the American College of Cardiology 7: 251–269, 1986
Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 73: 243–248, 1987
Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single vessel disease. Circulation 73: 710–717, 1986
Levin DC, Fallon JT. Significance of angiographie morphology of localized coronary stenosis: histophathological correlates. Circulation 66: 316–320, 1982
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New England Journal of Medicine 309: 396–403, 1983
Luchi RJ, Scott SM, Deupree RH, et al. Comparison of medical and surgical treatment for unstable angina pectoris: results of Veterans Administration Cooperative study. New England Journal of Medicine 316: 977–984, 1987
Maffrand JP, Bernat A, Delebassee D, Defreyen G, Cazenave JP, et al. ADP plays a key role in thrombogenesis in rats. Thrombosis and Haemostasis 59: 225–230, 1988
Maseri A, Chierchia S, L’Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation 62 (Suppl. V): V3–V13, 1980
McTavish D, Faulds D, Goa KL. Ticlopidine: an updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 40: 238–259, 1990
Meyer J, Schmitz HJ, Kiesslich T, et al. Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results. American Heart Journal 106: 973–980, 1983
Mikolich JR, Nicoloff NB, Robinson PH, Logue RB. Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 77: 375–379, 1980
Mizunp K, Miyamoto A, Satomura K, Kurita A. et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1: 809–812, 1991
Moise A, Theroux P, Taeymans Y, Sescoings B, Lesberance J, et al. Unstable angina and progression of coronary atherosclerosis. New England Journal of Medicine 309: 685–689, 1983
Mulcahy R. Natural history and prognosis of unstable angina. American Heart Journal 109: 753–759, 1985
Muller JE, Turi ZG, Pearle DL, et al. Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation 69: 728–739, 1984
Neri Serneri GG, Gensini GF, Poggersi L, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina. Lancet 1: 615–618, 1990
Nicklas J, Topol E, Kander N, O’Neill W, Waltin J, et al. Randomized, double-blind, placebo controlled trial of tissue plasminogen activator in unstable angina. Journal of the American College of Cardiology 13: 434–441, 1989
Nordlander R. Use of nitrates in the treatment of unstable angina and variant angina. Drugs 33 (Suppl. 4): 131–139, 1987
Page A, Gateau P, Ohayon J, et al. Intravenous nitroglycerin in unstable angina. In Lichtlen et al. (Eds) Nitrate III, cardiovascular effects, pp. 371–376, Springer Verlag, New York, 1981
Parodi O, Maseri A, Simonetti I. Management of unstable angina at rest by verapamil: a double-blind, cross-over study in coronary care unit. British Heart Journal 41: 167–174, 1979
Pasternak RC, Baughman KL, Fallon JT, Block PC. Scanning electron microscopy after coronary transluminal angioplasty of normal coronary arteries. American Journal of Cardiology 45: 591–598, 1980a
Plotnick GD. Approach to management of unstable angina. American Heart Journal 98: 243–255, 1979
Pucillo AL, Reison DS, Cannon PJ, Powers ER. Systemic and coronary hemodyamics during intravenous nitroglycerin infusion in patients with unstable angina. Journal of the American College of Cardiology 5: 505, 1985
Pugh R, Platt MR, Mills LJ, et al. Unstable angina pectoris: a randomized study of patients treated medically and surgically. American Journal of Cardiology 41: 1291–1298, 1978
Rackley CE. Role of isosorbide dinitrate in patients with unstable angina pectoris. American Heart Journal 110: 269–272, 1985
RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 2: 827–830, 1990
Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 65: 281–285, 1982
Roubin GS, Harris PJ, Eckhardt I, Hensley W, Kelly DT. Intravenous nitroglycerin in refractory unstable angina pectoris. Australian and New Zealand Journal of Medicine 12: 598–602, 1982
Russell RO, Resnekov K, Wölk M, et al. Unstable angina pectoris: National Cooperative Study Group to compare surgical and medical therapy. II. In-hospital experience and initial follow-up results in patients with one, two and three vessel disease. American Journal of Cardiology 42: 839–848. 1978
Rutherford JD. Unstable angina and thrombolysis. Chest (Suppl. 9): 156S-160S, 1990
Scanlon PJ. The intermediate coronary syndrome. Progress in Cardiovascular Disease 23: 351–364, 1982
Schreiber TL, Macina G, Bunnell P, et al. Thrombolytic therapy in unstable angina and non Q-wave myocardial infarction: a randomized trial of urokinase versus aspirin. Abstract. Journal of the American College of Cardiology 13: 191 A, 1989
Selden R, Niell WA, Ritzmann LW, Okies JE, Anderson RP. Medical versus surgical therapy for acute coronary insufficiency: a randomized study. New England Journal of Medicine 293: 1329–1333, 1975
Shah PK. Pathophysiology of unstable angina. Cardiology Clinics 9: 11–26, 1991
Shawl FA, Velasco CE, Goldbaum TS, Forman MB. Effect of coronary angioplasty on electrocardiographic changes in patients with unstable angina secondary to left anterior descending coronary artery disease. Journal of the American College of Cardiology 16: 325–331, 1990
Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, et al. Coronary angioscopy in patinets with unstable angina pectoris. New England Journal of Medicine 315: 913–919, 1986
Squire A, Cantor R, Packer M. Limitation of continuous intravenous nitroglycerin prophylaxis in patients with refractory angina at rest. Abstract. Circulation 66: 11–120, 1982
Steffenino G, Meier B, Finci L, Rutishauser W. Follow-up results of treatment of unstable angina by coronary angioplasty. British Heart Journal 57: 416–419, 1987
Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1: 1225–1228, 1981
Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. New England Journal of Medicine 319: 1105–1111, 1988
Theroux P, Taeymansy, Morissette D, Bosch X, Pelletier GB, et al. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. Journal of the American College of Cardiology 5: 717, 1985
Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, et al. and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. New England Journal of Medicine 317: 581–588, 1987
Wilentz FR, Sanborn FA, Haudenschild CC, Valeri CR, Ryan T, et al. Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury. Circulation 75: 636–642, 1987
Wilson RF, Holica MD, White CW. Quantitative angiographic morphology of coronary stenosis leading to myocardial infarction or unstable angina. Circulation 73: 286–293, 1986
Yusuf S. The use of beta-blockers in the acute phase of myocardial infarction. In Califf RM & Wagner GS (Eds) Acute coronary care, pp. 73–78, Martinus Nijhoff Publishers, Boston, 1986
Yusuf S, Peto R, Lewis J, et al. Beta-blockade during and after myocardial infarction. Progress in Cardiovascular Diseases 27: 335–371, 1985
Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease II. Unstable angina, heart failure, primary prevention with aspirin and risk factor modification. Journal of the American Medical Association 260: 2259–2263, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kar, S., Wakida, Y. & Nordlander, R. The High-Risk Unstable Angina Patient. Drugs 43, 837–848 (1992). https://doi.org/10.2165/00003495-199243060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199243060-00004